Health Care Activity – Page 10

Unlocking Direct-to-Consumer (DTC) Adoption: Leveraging Telehealth Programs for Enhanced Healthcare Access” ###

11 months ago talkbio0Tagged Adoption, clinical networks, Consumer health, Consumption of goods, Direct-to-Consumer, DTC, Health care facility, perspectives, pharma leaders, Policy, Primary Health Care, Reimbursement models, Services, Telemedicine, virtual care platforms

Direct-to-Consumer (DTC) digital health, Telehealth adoption, Virtual care platforms, Clinical networks, Consumer health and pharma leaders, Telemedicine services, Healthcare consumption, Primary care, Reimbursement models, Policy perspectives

Revolutionizing CAR-Ts: The Future of Automation and Decentralization in Cell and Gene Therapy Manufacturing

11 months ago11 months ago talkbio0Tagged Advanced therapies, Automation, CAR-Ts, Cells, Decentralization, Digital X-ray, gene therapy, Manufacture, Patient-Centered Care, Precision Medicine, Preventive monitoring, quality management systems, real-time, Regulatory Compliance, Supply chain logistics

Automation, Decentralization, CAR-Ts, Cell and gene therapy manufacturing, Advanced therapies, Personalized medicine, Regulatory compliance, Quality management systems, Supply chain logistics, Digital solutions, Real-time monitoring, Patient-centered care

Merck KGaA Evades Legal Action Following DOJ Collaboration on China Export Investigation

11 months ago talkbio0Tagged Avoidance, China, cooperation, DOJ, Evaluation, Export, Imprisonment (finding), Merck KGaA

Merck KGaA, DOJ, China, export scheme, cooperation, investigation, prosecution avoidance

Sen. Wyden Scrutinizes Pfizer’s Tax Rate Amidst Ongoing Investigation

11 months ago talkbio0Tagged Avoidance, Corporate, Drug Industry, Evaluation, financial transparency, Pfizer, Rating (action), Taxation, Wyden

Sen. Wyden, Pfizer, tax rate, investigation, corporate taxation, tax avoidance, pharmaceutical industry, financial transparency

Hims & Hers Expands Weight-Loss Solutions with GLP-1 Injections

11 months ago talkbio0Tagged Glucagon-Like Peptide 1, Hims & Hers, Injection of therapeutic agent, metabolic health, Obesity, Prescription procedure, Telemedicine, Weight-Loss

Hims & Hers, GLP-1 injections, weight-loss, telehealth, prescription medication, obesity treatment, metabolic health

FDA Revokes Accelerated Approval of Helsinn’s Cancer Drug at Company’s Request

11 months ago talkbio0Tagged Accelerated, Antineoplastic Agents, Approved, Clinical Trials, Helsinn, patient safety, regulatory, United States Food and Drug Administration

FDA, Helsinn, accelerated approval, cancer drug, company request, drug withdrawal, regulatory decision, clinical trials, patient safety.

Pfizer Temporarily Suspends Dosing in Advanced Duchenne Muscular Dystrophy (DMD) Trial After Patient Fatality

12 months ago talkbio0Tagged Clinical Trials, concerns, DMD, dosing, Duchenne, Evaluation, halt, late-stage study, Muscular Dystrophy, Muscular Dystrophy, Duchenne, Pfizer, Safety, Suspensions, Transitory

Pfizer, Duchenne Muscular Dystrophy (DMD), clinical trial, dosing halt, patient death, late-stage study, temporary suspension, safety concerns, investigation.

Reunion Neuroscience Secures $103 Million to Advance Psychedelic Therapies for Patients

12 months ago talkbio0Tagged Clinical Trials, Industry, mental health, mental health innovation, Neuroscience discipline, patient care, psychedelic therapies, Reunion Island

Reunion Neuroscience, psychedelic therapies, mental health, fundraising, clinical trials, mental health treatments, alternative therapies, mental health innovation, patient care, biotech industry.